Cannabinoid signaling in health and disease.

  title={Cannabinoid signaling in health and disease.},
  author={Y. Lu and H. Anderson},
  journal={Canadian journal of physiology and pharmacology},
  volume={95 4},
  • Y. Lu, H. Anderson
  • Published 2017
  • Medicine
  • Canadian journal of physiology and pharmacology
  • Cannabis sativa has long been used for medicinal purposes. To improve safety and efficacy, compounds from C. sativa were purified or synthesized and named under an umbrella group as cannabinoids. Currently, several cannabinoids may be prescribed in Canada for a variety of indications such as nausea and pain. More recently, an increasing number of reports suggest other salutary effects associated with endogenous cannabinoid signaling including cardioprotection. The therapeutic potential of… CONTINUE READING
    51 Citations
    New Insights in Cannabinoid Receptor Structure and Signaling.
    • 8
    Diverse TRPV1 responses to cannabinoids
    • 7
    A patent update on cannabinoid receptor 1 antagonists (2015-2018)
    • 6
    Distinct functions of endogenous cannabinoid system in alcohol abuse disorders
    • 10
    • Highly Influenced


    Should peripheral CB(1) cannabinoid receptors be selectively targeted for therapeutic gain?
    • 120
    Therapeutic potential of cannabis in pain medicine.
    • 104
    • Highly Influential
    • PDF
    Medical Marijuana: Clearing Away the Smoke
    • 114
    • Highly Influential
    • PDF
    Beta-caryophyllene is a dietary cannabinoid
    • 481
    • PDF
    Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression.
    • 186
    Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
    • 1,142
    • PDF
    CB2 cannabinoid receptor agonists: pain relief without psychoactive effects?
    • 181